Johnson & Johnson’s Q3 Profit Beats View, but Revenue Misses (JNJ)

By
A A A
Share |

Health products maker Johnson & Johnson( JNJ ) on Tuesday posted a better-than-expected third quarter profit, but its revenue fell short of analyst expectations.

The New Brunswick, NJ-based company reported third quarter net income of $3.42 billion, or $1.23 per share, compared with $3.35 billion, or $1.20 per share, in the year-ago period.

Revenue fell less than 1% from last year to $14.98 billion, hurt by a multiple product recalls in its consumer products division.

On average, Wall Street analysts expected a smaller profit of $1.15 per share, albeit on higher revenue of $15.24 billion.

Citing favorable foreign currency exchange rates, J&J boosted its 2010 full-year earnings forecast to a range of $4.70 to $4.80 per share, excluding items.

Johnson & Johnson shares fell $1.36, or -2.1%, in premarket trading Tuesday.

The Bottom Line
We have been recommending shares of Johnson & Johnson( JNJ ) since Oct.8. 2009, when the stock was trading at $60.71. The company has a 3.38% dividend yield of $63.86.

Johnson & Johnson( JNJ ) is a "Recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: JNJ

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

79%

Most Active by Volume

56,834,794
    $15.52 unch
47,736,761
  • $94.72 ▲ 0.83%
41,992,984
  • $2.47 ▲ 11.76%
40,893,734
  • $34.7901 ▲ 2.14%
39,324,803
  • $69.27 ▼ 0.19%
39,276,613
  • $7.28 ▲ 2.68%
39,084,483
  • $44.83 ▼ 0.01%
33,527,212
  • $26.02 ▲ 0.15%
As of 7/22/2014, 04:03 PM